EMEA (Europe, Middle East and Africa) Meningococcal Infections Vaccine Market Report 2017

October 2017 | 107 pages | ID: EB212F45577EN
QYResearch

Abstracts

In this report, the EMEA Meningococcal Infections Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K doses), revenue (Million USD), market share and growth rate of Meningococcal Infections Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Meningococcal Infections Vaccine market competition by top manufacturers/players, with Meningococcal Infections Vaccine sales volume (K doses), price (USD/dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi-Pasteur
• Beijing Tiantan Biological Products
• Shanghai Institute of Biological Products
• Wuhan Institute of Biological Products
• Lanzhou Institute of Biological Products
• Hualan Biological Engineering
• Chongqing Zhifei Biological Products
• Zhejiang Tianyuan Bio-Pharmaceutical
• Walvax Biotechnology
• Royal(Wuxi) Bio-Pharmaceutical

On the basis of product, this report displays the sales volume (K doses), revenue (Million USD), product price (USD/dose), market share and growth rate of each type, primarily split into

• Meningococcal Conjugate Vaccines
• Meningococcal Polysaccharide Vaccine
• Serogroup B Meningococcal Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K doses), market share and growth rate of Meningococcal Infections Vaccine for each application, including

• Children
• Preteens/Teens
• Adults

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Meningococcal Infections Vaccine Market Report 2017

1 MENINGOCOCCAL INFECTIONS VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine
  1.2.1 EMEA Meningococcal Infections Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Meningococcal Infections Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Meningococcal Conjugate Vaccines
  1.2.4 Meningococcal Polysaccharide Vaccine
  1.2.5 Serogroup B Meningococcal Vaccine
1.3 EMEA Meningococcal Infections Vaccine Market by Application/End Users
  1.3.1 EMEA Meningococcal Infections Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children
  1.3.3 Preteens/Teens
  1.3.4 Adults
1.4 EMEA Meningococcal Infections Vaccine Market by Region
  1.4.1 EMEA Meningococcal Infections Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Meningococcal Infections Vaccine (2012-2022)
  1.5.1 EMEA Meningococcal Infections Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Meningococcal Infections Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA MENINGOCOCCAL INFECTIONS VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Meningococcal Infections Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Meningococcal Infections Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Meningococcal Infections Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Meningococcal Infections Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Meningococcal Infections Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Meningococcal Infections Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Meningococcal Infections Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Meningococcal Infections Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Meningococcal Infections Vaccine (Volume) by Application
2.4 EMEA Meningococcal Infections Vaccine (Volume and Value) by Region
  2.4.1 EMEA Meningococcal Infections Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Meningococcal Infections Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Meningococcal Infections Vaccine Sales Price by Region (2012-2017)

3 EUROPE MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Meningococcal Infections Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Meningococcal Infections Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Meningococcal Infections Vaccine Sales and Market Share by Type
3.3 Europe Meningococcal Infections Vaccine Sales and Market Share by Application
3.4 Europe Meningococcal Infections Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Meningococcal Infections Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Meningococcal Infections Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Meningococcal Infections Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Meningococcal Infections Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Meningococcal Infections Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Meningococcal Infections Vaccine Sales and Market Share by Type
4.3 Middle East Meningococcal Infections Vaccine Sales and Market Share by Application
4.4 Middle East Meningococcal Infections Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Meningococcal Infections Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Meningococcal Infections Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Meningococcal Infections Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Meningococcal Infections Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Meningococcal Infections Vaccine Sales and Market Share by Type
5.3 Africa Meningococcal Infections Vaccine Sales and Market Share by Application
5.4 Africa Meningococcal Infections Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Meningococcal Infections Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Meningococcal Infections Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Meningococcal Infections Vaccine Sales and Growth Rate (2012-2017)

6 EMEA MENINGOCOCCAL INFECTIONS VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi-Pasteur
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Beijing Tiantan Biological Products
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shanghai Institute of Biological Products
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Wuhan Institute of Biological Products
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Lanzhou Institute of Biological Products
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Hualan Biological Engineering
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Chongqing Zhifei Biological Products
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zhejiang Tianyuan Bio-Pharmaceutical
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Walvax Biotechnology
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Royal(Wuxi) Bio-Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 MENINGOCOCCAL INFECTIONS VACCINE MANUFACTURING COST ANALYSIS

7.1 Meningococcal Infections Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Meningococcal Infections Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Meningococcal Infections Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Meningococcal Infections Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Meningococcal Infections Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Meningococcal Infections Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Meningococcal Infections Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Meningococcal Infections Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Meningococcal Infections Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Meningococcal Infections Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Meningococcal Infections Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Meningococcal Infections Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Meningococcal Infections Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Meningococcal Infections Vaccine
Figure EMEA Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2012-2022)
Figure EMEA Meningococcal Infections Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Meningococcal Conjugate Vaccines Product Picture
Figure Meningococcal Polysaccharide Vaccine Product Picture
Figure Serogroup B Meningococcal Vaccine Product Picture
Figure EMEA Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Meningococcal Infections Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Preteens/Teens Examples
Table Key Downstream Customer in Preteens/Teens
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure EMEA Meningococcal Infections Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Meningococcal Infections Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Meningococcal Infections Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Meningococcal Infections Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Meningococcal Infections Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Meningococcal Infections Vaccine Market Major Players Product Sales Volume (K doses) (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales Volume (K doses) of Major Players (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales Share by Players (2012-2017)
Figure 2016 Meningococcal Infections Vaccine Sales Share by Players
Figure 2017 Meningococcal Infections Vaccine Sales Share by Players
Figure EMEA Meningococcal Infections Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Meningococcal Infections Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Meningococcal Infections Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Meningococcal Infections Vaccine Revenue Share by Players
Table 2017 EMEA Meningococcal Infections Vaccine Revenue Share by Players
Table EMEA Meningococcal Infections Vaccine Sale Price (USD/dose) by Players (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales (K doses) and Market Share by Type (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Meningococcal Infections Vaccine by Type (2012-2017)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Meningococcal Infections Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Meningococcal Infections Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Type in 2016
Table EMEA Meningococcal Infections Vaccine Sale Price (USD/dose) by Type (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales (K doses) and Market Share by Application (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Meningococcal Infections Vaccine by Application (2012-2017)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share by Application in 2016
Table EMEA Meningococcal Infections Vaccine Sales (K doses) and Market Share by Region (2012-2017)
Table EMEA Meningococcal Infections Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Meningococcal Infections Vaccine by Region (2012-2017)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share in 2016
Table EMEA Meningococcal Infections Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Meningococcal Infections Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Region (2012-2017)
Figure EMEA Meningococcal Infections Vaccine Revenue Market Share Regions in 2016
Table EMEA Meningococcal Infections Vaccine Sales Price (USD/dose) by Region (2012-2017)
Figure Europe Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Meningococcal Infections Vaccine Sales (K doses) by Type (2012-2017)
Table Europe Meningococcal Infections Vaccine Market Share by Type (2012-2017)
Figure Europe Meningococcal Infections Vaccine Market Share by Type in 2016
Table Europe Meningococcal Infections Vaccine Sales (K doses) by Application (2012-2017)
Table Europe Meningococcal Infections Vaccine Market Share by Application (2012-2017)
Figure Europe Meningococcal Infections Vaccine Market Share by Application in 2016
Table Europe Meningococcal Infections Vaccine Sales (K doses) by Countries (2012-2017)
Table Europe Meningococcal Infections Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Meningococcal Infections Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Meningococcal Infections Vaccine Sales Market Share by Countries in 2016
Table Europe Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Meningococcal Infections Vaccine Revenue Market Share by Countries in 2016
Figure Germany Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure France Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure UK Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Russia Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Italy Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Benelux Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Meningococcal Infections Vaccine Sales (K doses) by Type (2012-2017)
Table Middle East Meningococcal Infections Vaccine Market Share by Type (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Market Share by Type (2012-2017)
Table Middle East Meningococcal Infections Vaccine Sales (K doses) by Applications (2012-2017)
Table Middle East Meningococcal Infections Vaccine Market Share by Applications (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Sales Market Share by Application in 2016
Table Middle East Meningococcal Infections Vaccine Sales Volume (K doses) by Countries (2012-2017)
Table Middle East Meningococcal Infections Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Meningococcal Infections Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Israel Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure UAE Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Iran Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Africa Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Meningococcal Infections Vaccine Sales (K doses) by Type (2012-2017)
Table Africa Meningococcal Infections Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales Market Share by Type in 2016
Table Africa Meningococcal Infections Vaccine Sales (K doses) by Application (2012-2017)
Table Africa Meningococcal Infections Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales Market Share by Application (2012-2017)
Table Africa Meningococcal Infections Vaccine Sales Volume (K doses) by Countries (2012-2017)
Table Africa Meningococcal Infections Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Meningococcal Infections Vaccine Sales Market Share by Countries in 2016
Table Africa Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Meningococcal Infections Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Meningococcal Infections Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Nigeria Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Egypt Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Algeria Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Table Sanofi-Pasteur Meningococcal Infections Vaccine Basic Information List
Table Sanofi-Pasteur Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Basic Information List
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Basic Information List
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Basic Information List
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Basic Information List
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Hualan Biological Engineering Meningococcal Infections Vaccine Basic Information List
Table Hualan Biological Engineering Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Basic Information List
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Basic Information List
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Walvax Biotechnology Meningococcal Infections Vaccine Basic Information List
Table Walvax Biotechnology Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Basic Information List
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2012-2017)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2012-2017)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Market Share in EMEA (2012-2017)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Infections Vaccine
Figure Manufacturing Process Analysis of Meningococcal Infections Vaccine
Figure Meningococcal Infections Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Infections Vaccine Major Manufacturers in 2016
Table Major Buyers of Meningococcal Infections Vaccine
Table Distributors/Traders List
Figure EMEA Meningococcal Infections Vaccine Sales (K doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Price (USD/dose) and Trend Forecast (2017-2022)
Table EMEA Meningococcal Infections Vaccine Sales (K doses) Forecast by Region (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Meningococcal Infections Vaccine Sales (K doses) Forecast by Countries (2017-2022)
Figure Europe Meningococcal Infections Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Meningococcal Infections Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Meningococcal Infections Vaccine Sales (K doses) Forecast by Countries (2017-2022)
Figure Middle East Meningococcal Infections Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Meningococcal Infections Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Meningococcal Infections Vaccine Sales (K doses) Forecast by Countries (2017-2022)
Figure Africa Meningococcal Infections Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Meningococcal Infections Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Meningococcal Infections Vaccine Sales (K doses) Forecast by Type (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Meningococcal Infections Vaccine Sales (K doses) Forecast by Application (2017-2022)
Figure EMEA Meningococcal Infections Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources